| |
|
|
Session 51
Poster Presentations Novel Vaccine Approaches Thursday 1:30 - 3:30 pm Hall D |
| 422 | Tat Protein Production in Plants; A New Approach to Mucosal Delivery of an HIV-1 Vaccine Candidate A. V. Karasev*, K. J. Shon, B. Aiamkitsumrit, I. Zwierzynski, H. Koprowski Thomas Jefferson Univ, Doylestown, PA |
| 423 | Evaluation of MHC Alloimmunization as an HIV Vaccine Strategy Using SIV/Macaque Model Y. Guan*1, M. A. Luscher2, E. Rakasz3, D. I. Watkins3, T. Rustam1, M. Candido1, J. Tartaglia4, K. S. MacDonald1 1Univ of Toronto and Mount Sinai Hosp, Canada; 2Univ of Toronto and Univ Hlth Network, Canada; 3Wisconsin Reg Primate Res Ctr, Univ of Wisconsin, Madison; and 4Aventis Paster, Toronto, Canada |
| 424 | Study of Allo-immunization in Humans During Sexual Intercourse and Effects on HIV Infectivity B. S. Peters*, T. Whittal, K. Bubaahmady, K. Gray, R. Vaughan, T. Lehner King's Coll, London, UK |
| 425 | Comparison between Intradermal and Intramuscular Routes of Administration in the Induction of Multispecific CD8+ Lymphocytes in Rhesus Macaques Vaccinated with NEF and GAG Derived Lipopeptides Z. Coutsinos*1, P. Villefroy1, H. Gras-Masse2, C. Beyer3, J. G. Guillet1, I. Bourgault-Villada1 1Cochin Inst, Paris, France; 2Lab Synthesis, Structure and Function of Biomolecules, Inst Pasteur de Lille; and 3Inst of Virology, Faculty of Med, Univ Pasteur de Strasbourg |
| 426 | Long-term Specific Immune Responses Induced in Humans by an HIV-1 Lipopeptide Vaccine: Immunodominance Ranking of CD8+ T-cell Epitopes H. Gahery-Segard*1, G. Pialoux2, S. Figueiredo1, C. Igea1, M. Surenaud1, H. Gras-Masse3, J-P. Levy J-G. Guillet4, J-G. Guillet1 1INSERM U567, Paris, France; 2Tenon Hosp, Paris, France; 3Inst Pasteur, Lille, France; and 4Inst Pasteur, Paris, France |
| 427 | Preclinical Testing of an HIV-1 Envelope-containing Heat-treated Pseudovirion Vaccine B. Poon*1,2,3, J. F. Hsu1,2, V. Gudeman1,4, O. Negrete1,2, I. S. Y. Chen1,2,3, K. Grovit-Ferbas1,2,4 1David Geffen Sch of Med at UCLA, Los Angeles, CA; 2Univ of California at Los Angeles, AIDS Inst; 3Jonsson Comprehensive Cancer Ctr, Los Angeles, CA; and 4Veterans Admin Greater Los Angeles Hlthcare Sys, CA |
| 428 | Transduction of Human Dendritic Cells Using Attenuated Salmonella typhimurium as a Vaccine Strategy against HIV-1 D. Gurner*, Y. Huang, D. D. Ho Aaron Diamond AIDS Res Ctr, Rockefeller Univ, New York, NY |
| 429 | High Cellular Immune Responses to SIV Antigens following Recombinant DNA Prime and Listeria Monocytogenes Boost in the Rhesus Macaque Model J. D. Boyer*1, T. Robinson1, M. Lewis2, S. Carlarota1, D. B. Weiner1, Y. Paterson1 1Univ of Pennsylvania, Philadelphia and 2Southern Res Inst, Frederick, MD |
| 430 | Recombinant Yeast Vaccine Induces Maturation of Human Dendritic Cells in HIV-1 Infected Patients M. Barron*, N. Blyveis, C. Wilson Univ of Colorado Hlth Sci Ctr, Denver |
| 431 | Ancestral State Reconstructions in the Formulation of HIV Vaccines J.I. Mullins*1, G.H. Learn1, F. Li1, A.G. Rodrigo2 1Univ of Washington, Seattle and 2Univ of Auckland, New Zealand |
| 432 | New Murine Model for HIV-1 Infection and Rapid Vaccine Screening M. Ayash-Rashkovsky*1, G. Borkow1, H. Davis2, R. B. Moss3, Z. Bentwich1 1Hebrew Univ Med Sch, Jerusalem, Israel; 2Coley Pharmaceutical Canada, Ottawa, Canada; and 3Immune Response Corp, San Diego, CA |
| 433 | AIDS Vaccines That Allow HIV-1 to Infect and Escape Immunological Control: A Mathematical Analysis of Mass Vaccination J. A. Bogaards*1, M. van Ballegooijen2, M. C Boerlijst2, G-J. Weverling1, J. Goudsmit3 1Academic Med Ctr, Univ of Amsterdam, The Netherlands; 2Section Population Biology, Univ of Amsterdam, The Netherlands; and 3Ctr for Poverty-related Communicable Diseases, Amsterdam, The Netherlands |
| 434 | Parasitic Infection Alters the Quality of the Immune Response to HIV-1 Vaccines J. D. Boyer*1, T. Robinson1, D. Artis1, D. B. Weiner2, P. Scott2 1Univ of Pennsylvania, Philadelphia and 2Veterinary Sch, Univ of Pennsylvania, Philadelphia, PA |
| 434a | Prime-Boost Vaccination with Recombinant Mycobacterium bovis Bacillus Calmette-Guérin and Vaccinia Strain DIs Elicits Protective Immunity against Pathogenic SHIV Infection in Macaques' Naoki Yamamoto*1, Tadashi Nakasone2, Yasuyuki Izumi2, Kazuhiro Matsuo2, Yasushi Ami2, Shudo Yamazaki2, Mitsuo Honda2 1National Institute of Infectious diseases,Japan and 2National Institute of Infectious diseases,Japa |